
    
      Secondary objectives include the following: to obtain and archive blood samples to 1) detect
      frequency of vector marking in peripheral blood mononuclear cells when clinically or
      scientifically indicated, such as in the event of participant development of second
      malignancy, autoimmune disease, hematologic abnormality, or neurologic event, and; 2) To
      obtain and archive blood samples to detect and characterize clonal proliferation events
      occurring in gene transfer trials when clinically or scientifically indicated.
    
  